Vaccines, virucides and drugs against HIV/AIDS: Hopes and optimisms for the future

A. A. Al-Jabri, F. Q. Alenzi

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)


More than 25 million lives have been claimed by AIDS and 33.2 million people are estimated to have HIV, the majority of which are living in the underdeveloped countries. Failed tests on vaccines, virucides and complete virus eradication have caused scientists to refocus on the basic questions of what makes an effective HIV immune response. The "gloom" over disappointing research results on vaccine development and virucides "threatens to overshadow more positive" HIV/AIDS-related news, such as findings that male circumcision might reduce the likelihood of HIV transmission and that giving antiretroviral drugs to "high-risk" HIV-negative people (pre-exposure prophylaxis) could help protect them from infection. Something like pre-exposure prophylaxis has a good chance of becoming available before we have a 100% efficacious vaccine. The future in the field of HIV/AIDS will be much brighter if global research is appropriately coordinated and sufficient funds are available.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalOpen AIDS Journal
Publication statusPublished - 2009


  • AIDS
  • Drugs
  • HIV
  • Immune response
  • Vaccines
  • Virucides

ASJC Scopus subject areas

  • Public Health, Environmental and Occupational Health
  • Infectious Diseases
  • Virology


Dive into the research topics of 'Vaccines, virucides and drugs against HIV/AIDS: Hopes and optimisms for the future'. Together they form a unique fingerprint.

Cite this